Late radiotherapy toxicity after prostate cancer treatment: Influence of hormonal therapy

Urology

Volumn 66, Issue 3, 2005, Pages 566-570

  Jani, Ashesh B ^a   Gratzle, John ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BEAM THERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CHI SQUARE TEST; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; GASTROINTESTINAL TOXICITY; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RADIATION INJURY; REGRESSION ANALYSIS; STATISTICAL SIGNIFICANCE; URINARY TRACT DISEASE;

AGED; ANILIDES; ANTINEOPLASTIC AGENTS, HORMONAL; FLUTAMIDE; GASTROINTESTINAL DISEASES; GOSERELIN; HUMANS; LEUPROLIDE; MALE; MALE UROGENITAL DISEASES; PROSTATIC NEOPLASMS; RADIATION INJURIES; TIME FACTORS;

EID: 24144455393     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urology.2005.03.081     Document Type: Article

References (30)

1. A.B. Jani, S. Hellman Early prostate cancer clinical decision-making Lancet 361 2003 1048 1053
2. H. Gronberg Prostate cancer epidemiology Lancet 361 2003 859 864
3. A.B. Jani, J.C. Roeske, C. Rash Intensity-modulated radiation therapy for prostate cancer Clin Prostate Cancer 2 2003 98 105
4. C. Huggins Endocrine-induced regression of cancers Science 156 1967 1050 1054
5. Prostate Cancer Trialists' Collaborative Group Maximum androgen blockade in advanced prostate cancer an overview of 22 randomised trials with 3283 deaths in 5710 patients Lancet 346 1995 265 269
6. A.B. Jani The effectiveness of combining hormone therapy and radiotherapy in the treatment of prostate cancer Expert Opin Pharmacother 5 2004 2469 2477
7. M.V. Pilepich, K. Winter, M.J. John Phase III Radiation Therapy Oncology Group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate Int J Radiat Oncol Biol Phys 50 2001 1243 1252
8. J. Laverdiere, J.L. Gomez, L. Cusan Beneficial effect of combination hormonal therapy administered prior and following external beam radiation therapy in localized prostate cancer Int J Radiat Oncol Biol Phys 37 1997 247 252
9. C.A. Lawton, K. Winter, K. Murray Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate Int J Radiat Oncol Biol Phys 49 2001 937 946
10. A.B. Jani, J. Kao, S. Hellman Hormone therapy adjuvant to external beam radiotherapy for locally advanced prostate carcinoma a complication-adjusted number-needed-to-treat analysis Cancer 98 2003 2351 2361
11. A.B. Jani, A. Basu, I. Abdalla The impact of hormone therapy when combined with external beam radiotherapy for early-stage, intermediate- or high-risk prostate cancer Am J Clin Oncol 26 2003 382 385
12. L.N. Lee, R.G. Stock, N.N. Stone Role of hormonal therapy in the management of intermediate- to high-risk prostate cancer treated with permanent radioactive seed implantation Int J Radiat Oncol Biol Phys 52 2002 444 452
13. A.V. D'Amico, R. Whittington, S.B. Malkowicz Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer JAMA 280 1998 969 974
14. A. Martinez, R. Galalae, J. Gonzalez No apparent benefit at 5 years from a course of neoadjuvant/concurrent androgen deprivation for patients with prostate cancer treated with a high total radiation dose J Urol 170 2003 2296 2301
15. A.B. Jani, J. Kao, R. Heimann Hormone therapy adjuvant to external beam radiotherapy for early prostate cancer a complication-adjusted number-needed to treat (NNT) analysis Int J Radiat Oncol Biol Phys 61 2005 687 694
16. A.V. D'Amico, J. Manola, M. Loffredo 6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer a randomized controlled trial JAMA 292 2004 821 827
17. J.M. Holzbeierlein, E. Castle, J.B. Thrasher Complications of androgen deprivation therapy prevention and treatment Oncology 18 2004 303 309
18. A.B. Jani, M. Sokoloff, A. Shalhav Androgen ablation adjuvant to post-prostatectomy radiotherapy a complication-adjusted number-needed to treat analysis Urology 64 2004 976 981
19. R.K. Valicenti, K. Winter, J.D. Cox RTOG 94-06 is the addition of neoadjuvant hormonal therapy to dose-escalated 3D conformal radiation therapy for prostate cancer associated with treatment toxicity? Int J Radiat Oncol Biol Phys 57 2003 614 620
20. M.J. Zelefsky, A. Harrison Neoadjuvant androgen ablation prior to radiotherapy for prostate cancer reducing the potential morbidity of therapy Urology 49 3A suppl 1997 38 45
21. M.J. Zelefsky, S.A. Leibel, C.M. Burman Neoadjuvant hormonal therapy improves the therapeutic ratio in patients with bulky prostatic cancer treated with three-dimensional conformal radiation therapy Int J Radiat Oncol Biol Phys 29 1994 755 761
22. G. Sanguineti, S. Agostinelli, F. Foppiano Adjuvant androgen deprivation impacts late rectal toxicity after conformal radiotherapy of prostate carcinoma Br J Cancer 86 2002 1843 1847
23. J.D. Forman, R. Kumar, G. Haas Neoadjuvant hormonal downsizing of localized carcinoma of the prostate effects on the volume of normal tissue irradiation Cancer Invest 13 1995 8 15
24. K.R. Blank, R. Whittington, B. Arjomandy Neoadjuvant androgen deprivation prior to transperineal prostate brachytherapy smaller volumes, less morbidity Cancer J Sci Am 5 1999 370 373
25. F.E. Yang, G.T. Chen, P. Ray The potential for normal tissue dose reduction with neoadjuvant hormonal therapy in conformal treatment planning for stage C prostate cancer Int J Radiat Oncol Biol Phys 33 1995 1009 1017
26. A.K. Lee, A. Melancon, R. Cheung Under-dosing of potential microscopic prostate cancer with IMRT after neoadjuvant hormonal therapy Int J Radiat Oncol Biol Phys 60 2004 S449
27. Jani AB, Gratzle J, and Myers M: Impact of hormone therapy on acute radiotherapy toxicity in the treatment of prostate cancer. Prostate Cancer Prostatic Dis (in press).
28. B. Dawson-Saunders, R.G. Trapp Basic and Clinical Biostatistics 1990 Prentice Hall East Norwalk, Connecticut
29. Radiation Therapy Oncology Group (RTOG): Toxicity Information. Sections 7-8: Acute and Late Radiation Morbidity Criteria. Available at http://www.rtog.org/members/toxicity/main.html. Accessed: March 2, 2005.
30. A. Agresti Categorical Data Analysis 2nd ed 2002 Wiley New York